Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Advances in Rheumatology (London, England)|May 3, 2024
IgG4-related disease-rare but you should not forget itFrederico Augusto Gurgel Pinheiro, Ivanio Alves Pereira, Alexandre Wagner Silva de Souza, et al.
Seminars in Ultrasound, CT, and MR|August 9, 2023
The Role of MRI in Differentiating Demyelinating and Inflammatory (not Infectious) MyelopathiesJoão Vitor Gerdulli Tamanini, João Vitor Sabino, Rafael Alves Cordeiro, et al.
Advances in Rheumatology (London, England)|August 22, 2024
Inflammatory turmoil within: an exploration of autoinflammatory disease genetic underpinnings, clinical presentations, and therapeutic approachesKátia Tomie Kozu, Renan Rodrigues Neves Ribeiro do Nascimento, Patrícia Pontes Aires, et al.
Advances in Rheumatology (London, England)|September 16, 2024
Uncovering the knowledge about systemic amyloidosis relevant to the rheumatologistsIvanio Alves Pereira, Nilton Salles Rosa Neto, Renan Rodrigues Neves Ribeiro do Nascimento, et al.
Advances in Rheumatology (London, England)|September 28, 2024
Rare diseases: What rheumatologists need to know?Renan Rodrigues Neves Ribeiro do Nascimento, Daniela Gerent Petry Piotto, Eutilia Andrade Medeiros Freire, et al.
International Journal of Rheumatic Diseases|March 5, 2023
Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD studySamuel Katsuyuki Shinjo, Minchul Kim, Leonardo Santos Hoff, et al.
Frontiers in Pharmacology|March 6, 2025
Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registryAntonio Vitale, Valeria Caggiano, Flavia Leone, et al.
Frontiers in Medicine|January 28, 2026
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registriesValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Frontiers in Pharmacology|March 24, 2025
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA networkAntonio Vitale, Flavia Leone, Valeria Caggiano, et al.
The Journal of Rheumatology|November 15, 2024
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease RegistryPiero Ruscitti, Ilenia Di Cola, Antonio Vitale, et al.
Pageof 3